BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $96 at Morgan Stanley
Tweet
Share
E-mailGet Alerts BMRN Hot Sheet
Price: $70.24 +0.99%
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
25 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Morgan Stanley analyst Matthew Harrison raised the price target on BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) to $96.00 (from $90.00) while maintaining a Equalweight rating.
You May Also Be Interested In
- BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $114 at Canaccord
- Vera Therapeutics (VERA) PT Lowered to $80 at Goldman Sachs
- Marvell (MRVL) PT Raised to $195 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
